GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1126 - 1150 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G21675ZL
1838
IgG Patient 2 3 mild
G21675ZL
1378
IgM Patient 2 3 mild
G21675ZL
1242
IgA Patient 3 -180 mild
G21675ZL
382
IgA Patient 3 11 mild
G21675ZL
520
IgG Patient 3 -180 mild
G21675ZL
83
IgM Patient 3 -180 mild
G21675ZL
398
IgA Patient 3 4 mild
G21675ZL
495
IgG Patient 3 11 mild
G21675ZL
104
IgG Patient 3 4 mild
G21675ZL
86
IgM Patient 3 11 mild
G21675ZL
539
IgM Patient 3 4 mild
G21675ZL
452
IgA Patient 4 12 mild
G21675ZL
488
IgG Patient 4 12 mild
G21675ZL
108
IgM Patient 4 12 mild
G21675ZL
551
IgA Patient 1 10 moderate
G22768VO
368
IgA Patient 1 22 moderate
G22768VO
416
IgA Patient 1 6 moderate
G22768VO
327
IgG Patient 1 10 moderate
G22768VO
29
IgG Patient 1 22 moderate
G22768VO
42
IgG Patient 1 6 moderate
G22768VO
27
IgM Patient 1 10 moderate
G22768VO
52
IgM Patient 1 22 moderate
G22768VO
192
IgM Patient 1 6 moderate
G22768VO
47
IgA Patient 2 15 mild
G22768VO
984

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024